Mucinex, and Dayquil. The agency said the presence of phenylephrine doesn’t affect how the other active ingredients work. “It ...

U.S. health officials proposed banning an ingredient used in popular oral decongestants, a step toward removing dozens of ...

The Food and Drug Administration proposed ending the use of a common ingredient in many popular over-the-counter cold and allergy medications because it doesn't actually relieve nasal congestion. The ...

“I took Mucinex 30 minutes before baby-dancing,” TikTok user Amanda MacGibbon shared in March. She said she also took the antioxidant supplement coenzyme Q10 and the anti-diabetic drug ...

Mucinex contains an active ingredient ... Guaifenesin is considered pregnancy category C by the U.S. Food and Drug Administration. That classification means means there's no data on human fetuses ...

If you have a bottle of Mucinex in your medicine cabinet, you may need to throw it away. Earlier this week, drugmaker RB recalled certain lots of over-the-counter Mucinex Fast-Max liquid products ...

Oxymetazoline HCl 0.05%; nasal spray; contains benzalkonium chloride, menthol, camphor, eucalyptol. <6yrs: not recommended. Shake well. ≥6yrs: 2–3 sprays in each nostril not more than every 10 ...

The ingredient has been used alone and in combination with other pain killers, cough suppressants and other agents meant to ease cold and flu symptoms in medications like Tylenol, Mucinex and Benadryl ...

Guaifenesin 100mg; per 5mL; grape flavor; alcohol free; contains sodium 3mg. <4yrs: do not use. 4–5yrs: 2.5–5mL every 4 hours. 6–11yrs: 5–10mL every 4 hours. Max 6 doses/day.

Despite the crucial need for new antibiotics, there has been little innovation in the past 20 years. According to a report from the Biotechnology Innovation Organization, “more than 82% of all ...

Antibiotic resistance is the ability of bacteria to resist the effects of antibiotics, a type of drug - such as penicillin or ciprofloxacin - that kills or stops the growth of bacteria. When bacteria ...

The promising new drug is currently in the final preclinical stages with preparations underway for first-in-human clinical trials. Recce’s new compound is a broad-spectrum antibiotic initially ...